Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: REJUVENICS TECHNOLOGIES LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-16 to 2022-03-15
Current total value of award: $438213
Description: NO COST EXTENSION - TOPIC 399: COMBINATORY TREATMENT UTILIZING RADIATION TO LOCALLY ACTIVATE SYSTEMICALLY DELIVERED THERAPEUTICS.